CRSP EV to Operating Cash Flow

Crispr Therapeutics Ag · EV to Operating Cash Flow

CRSP logo

CRSP EV to Operating Cash Flow

Current (TTM)-14.42×
CRSP Quarterly EV/OCF (0.00× → -68.94×)
High-resolution chart · PNG

CRSP ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag EV to Operating Cash Flow — Quarterly
Period endingEV to Operating Cash Flow
-68.9393×
-45.3042×
-51.3803×
-71.2631×
-37.3498×
-53.9172×
-65.7454×
-37.4717×
-45.2838×
46.5072×
-50.3538×
-83.2604×
-31.8252×
392.5926×
-28.3824×
-46.0027×
-31.3548×
-32.4946×
-59.3984×
-94.8754×
13.4078×
-80.1401×
-118.609×
-64.2677×
-123.2341×
-33.2198×
771.4637×
12.4371×
-59.1445×
-33.0563×
-35.7722×
-76.1011×
-96.479×
-77.3665×
-56.4239×
-29.1698×
-22.9652×
-24.6011×
-25.1955×
-26.9989×
-23.0228×
-21.1909×
4.2777×
0×
0×
0×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.